Convergence Investment Partners LLC Acquires 3,095 Shares of Cigna Group $CI

Convergence Investment Partners LLC lifted its position in shares of Cigna Group (NYSE:CI) by 43.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,193 shares of the health services provider’s stock after buying an additional 3,095 shares during the period. Convergence Investment Partners LLC’s holdings in Cigna Group were worth $2,719,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Norges Bank acquired a new stake in Cigna Group in the 4th quarter valued at approximately $1,019,790,000. Northwestern Mutual Wealth Management Co. boosted its position in Cigna Group by 13,333.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock worth $900,912,000 after acquiring an additional 3,141,844 shares during the last quarter. Dodge & Cox boosted its position in Cigna Group by 19.7% during the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after acquiring an additional 1,833,389 shares during the last quarter. Boston Partners grew its stake in shares of Cigna Group by 314.6% during the 4th quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock worth $450,856,000 after acquiring an additional 1,243,056 shares in the last quarter. Finally, GQG Partners LLC grew its stake in shares of Cigna Group by 14.3% during the 4th quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after acquiring an additional 972,302 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Insider Activity at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

CI has been the topic of a number of research reports. Jefferies Financial Group cut their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. Deutsche Bank Aktiengesellschaft lowered shares of Cigna Group from a “buy” rating to a “hold” rating and lowered their price target for the company from $303.00 to $302.00 in a research note on Wednesday, May 20th. Morgan Stanley boosted their price target on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 20th. Royal Bank Of Canada increased their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research note on Friday, May 1st. Finally, Sanford C. Bernstein raised their price objective on Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a report on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.

Cigna Group Price Performance

Shares of CI opened at $284.01 on Tuesday. The company’s 50-day moving average is $286.59 and its 200-day moving average is $280.48. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market capitalization of $75.13 billion, a PE ratio of 12.04, a PEG ratio of 1.08 and a beta of 0.29. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same period in the prior year, the company posted $6.74 earnings per share. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities analysts forecast that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were given a dividend of $1.56 per share. The ex-dividend date was Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.